Skip to main content
. Author manuscript; available in PMC: 2006 Jan 27.
Published in final edited form as: Nat Med. 2005 Apr 24;11(5):491–498. doi: 10.1038/nm1238

Table 1.

Change (%) from baseline in alveolar diameters induced by VEGFR blockade and ceramide synthesis inhibitors.

Treatment VEGF R-inh Vehicle
Inhibitor (mg/kg) PBS FB1 (2.2) FB1 (1.1) Myriocin (1.0) Myriocin (0.3) PBS FB1 (2.2) FB1 (1.1) Myriocin (1.0)
Mouse 17.8* 4.3# 9.3# −3.3# −1.8# 0 12.9* 4.7 −1.8
Rat 21.8* −2.6# 17.5* n/a n/a 0 9.7* n/a n/a

Abbreviations: n-a not assessed.

*

p <0.05 versus Vehicle + PBS

#

p <0.05 versus VEGFR-inh + PBS